Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5479)
All Articles published online
|
Apr 14, 2012 (publication date) through Dec 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Herreros-Villanueva M, Hijona E, Cosme A, Bujanda L. Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol 2012; 18(14): 1565-1572 [PMID: 22529684 DOI: 10.3748/wjg.v18.i14.1565] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i14/1565.htm |
| Number | Citing Articles |
| 1 |
Valerio Falasca, Marco Falasca. Targeting the Endocannabinoidome in Pancreatic Cancer. Biomolecules 2022; 12(2): 320 doi: 10.3390/biom12020320
|
| 2 |
Margareta Heby, Jakob Elebro, Björn Nodin, Karin Jirström, Jakob Eberhard. Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma. BMC Clinical Pathology 2015; 15(1) doi: 10.1186/s12907-015-0009-1
|
| 3 |
Archana Bhaw-Luximon, Nowsheen Goonoo, Dhanjay Jhurry. Nanobiomaterials in Cancer Therapy. 2016; : 147 doi: 10.1016/B978-0-323-42863-7.00006-2
|
| 4 |
Huahui Zeng, Xin Zhu, Qikang Tian, Yinyin Yan, Lan Zhang, Min Yan, Ruiqin Li, Xiaofang Li, Guoqiang Wang, Jinlian Ma, Yufang Su, Xiangbo Zhang, Linyu Ma, Zhenqiang Zhang, Xiangxiang Wu.
In vivo
antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
. Drug Delivery 2020; 27(1): 848 doi: 10.1080/10717544.2020.1770370
|
| 5 |
Richard Fristedt, Jacob Elebro, Alexander Gaber, Liv Jonsson, Margareta Heby, Yulyana Yudina, Björn Nodin, Mathias Uhlén, Jakob Eberhard, Karin Jirström, Nupur Gangopadhyay. Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis. PLoS ONE 2014; 9(11): e112728 doi: 10.1371/journal.pone.0112728
|
| 6 |
Bassem Amr, Andrew MacCormick, Gemma Miles, Golnaz Shahtahmassebi, Carl Roobottom, David Stell. Estimation of the organ of origin of peri-ampullary malignancy by preoperative CT scan. Acta Radiologica 2023; 64(3): 891 doi: 10.1177/02841851221096284
|
| 7 |
Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park. Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer. Gastrointestinal Endoscopy 2018; 88(6): 926 doi: 10.1016/j.gie.2018.06.024
|
| 8 |
Zhong Yu, Wa Zhong, Zhi-Ming Tan, Ling-Yun Wang, Yu-Hong Yuan. Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer. American Journal of Clinical Oncology 2015; 38(3): 322 doi: 10.1097/COC.0b013e3182a46782
|
| 9 |
Henricus J. M. Handgraaf, Martin C. Boonstra, Arian R. Van Erkel, Bert A. Bonsing, Hein Putter, Cornelis J. H. Van De Velde, Alexander L. Vahrmeijer, J. Sven D. Mieog. Current and Future Intraoperative Imaging Strategies to Increase Radical Resection Rates in Pancreatic Cancer Surgery. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/890230
|
| 10 |
Fei Chen, Yang Guo, Liangjing Wang. The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer. Gastrointestinal Tumors 2015; 2(3): 131 doi: 10.1159/000435764
|
| 11 |
Tarik Ghadban, Judith L. Dibbern, Matthias Reeh, Jameel T. Miro, Tung Y. Tsui, Ulrich Wellner, Jakob R. Izbicki, Cenap Güngör, Yogesh K. Vashist. HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. Apoptosis 2017; 22(3): 369 doi: 10.1007/s10495-016-1332-4
|
| 12 |
Molecular Processes Involved in Pancreatic Cancer and Therapeutics. Current Chemical Biology 2021; 15(1): 85 doi: 10.2174/2212796814999201008130819
|
| 13 |
Thais Chile, Maria Angela Henriques Zanella Fortes, Maria Lúcia Cardillo Corrêa-Giannella, Helena Paula Brentani, Durvanei Augusto Maria, Renato David Puga, Vanessa de Jesus R de Paula, Marcia Saldanha Kubrusly, Estela Maria Novak, Telésforo Bacchella, Ricardo Rodrigues Giorgi. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-451
|
| 14 |
Petra Vychytilova-Faltejskova, Ondrej Slaby. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum 2015; 106: 75 doi: 10.1007/978-3-0348-0955-9_4
|
| 15 |
Margareta Heby, Emelie Karnevi, Jacob Elebro, Björn Nodin, Jakob Eberhard, Kapo Saukkonen, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund, Karin Jirström, Anna H. Larsson. Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67187-z
|
| 16 |
Laura Kuhlmann, Wiebke M. Nadler, Alexander Kerner, Sabrina A. Hanke, Elisa M. Noll, Christian Eisen, Elisa Espinet, Vanessa Vogel, Andreas Trumpp, Martin R. Sprick, Christoph P. Roesli. Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma. Pancreas 2017; 46(3): 311 doi: 10.1097/MPA.0000000000000743
|
| 17 |
Tasneem Mokhtar Radwan, Maher Abdel‐Aziz El‐Hashash, Ashraf Abdel‐Hamid Farouk Wasfy, Suzan Abdelhalim Abdallah. Synthesis and Characteristics of Metastable 2‐Benzyl‐4H‐3,1‐benzoxazin‐4‐one as Anticancer Agent and its Comparison with other Heterocyclic Compounds. ChemistrySelect 2019; 4(48): 14056 doi: 10.1002/slct.201902773
|
| 18 |
Xiao Zhi, Wei Chen, Fei Xue, Chao Liang, Bryan Wei Chen, Yue Zhou, Liang Wen, Liqiang Hu, Jian Shen, Xueli Bai, Tingbo Liang. OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine bothin vitroandin vivo. Oncotarget 2015; 6(28): 26230 doi: 10.18632/oncotarget.4579
|
| 19 |
Xiaoke Tan, Xin Zhu, Duanjie Xu, Yanmei Shi, Zhenzhen Wang, Mingzhuo Cao, Kai Hu, Lingzhou Zhao, Junwei Zhao, Mingsan Miao, Huahui Zeng, Xiangxiang Wu. A mitochondria-targeted nano-platform for pancreatic cancer therapy. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.951434
|
| 20 |
Chaobin He, Yize Mao, Jun Wang, Fangting Duan, Xiaojun Lin, Shengping Li. Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4240-x
|
| 21 |
Alisha A. Lad, Yinjiao Ma, Jung Ae Lee, Yikyung Park, Linda M. Liao, Rachael Stolzenberg-Solomon, Adetunji T. Toriola. No Association Between Nonsteroidal Anti-inflammatory Drug Use and Pancreatic Cancer Incidence and Survival. Pancreas 2017; 46(5): e43 doi: 10.1097/MPA.0000000000000809
|
| 22 |
Margareta Heby, Sebastian Lundgren, Björn Nodin, Jacob Elebro, Jakob Eberhard, Karin Jirström. Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1444-4
|
| 23 |
|
| 24 |
Cheng Wang, Biao Liu, Xuelian Xu, Bo Zhuang, Hongxia Li, Jiaqi Yin, Mengyi Cong, Wei Xu, Aiping Lu. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Oncotarget 2016; 7(7): 8360 doi: 10.18632/oncotarget.7073
|
| 25 |
Carlos Fortea-Sanchis, Luis Gómez-Quiles, David Martínez-Ramos, Javier Escrig Sos, Gabriel Alejandro Paiva-Coronel, Raquel Queralt-Martín, Álvaro Villarín-Rodríguez, Laura Granel-Villach, José Luis Salvador-Sanchis. Diagnostic Yield of Pancreatic Percutaneous Puncture Depending on the Size of the Lesion. Cirugía Española (English Edition) 2013; 91(6): 361 doi: 10.1016/j.cireng.2013.10.025
|
| 26 |
Rui Zhang, Shangen Zheng, Yuwen Du, Yuanyuan Wang, Wenqiao Zang, Guoqiang Zhao. Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients. Diagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-61
|
| 27 |
Helmut Oettle. Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedside. Cancer Treatment Reviews 2014; 40(9): 1039 doi: 10.1016/j.ctrv.2014.07.003
|
| 28 |
Baoyue Ding, Md Arif Wahid, Zhijun Wang, Chen Xie, Arvind Thakkar, Sunil Prabhu, Jeffrey Wang. Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells. Nanoscale 2017; 9(32): 11739 doi: 10.1039/C7NR03016A
|
| 29 |
Shin-Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32159-x
|
| 30 |
Sally Temraz, Farah Nassar, Miza Salim Hammoud, Deborah Mukherji, Eileen M. O'Reilly, Haifa Dbouk, Fadi Farhat, Maya Charafeddine, Walid Faraj, Mohammad J. Khalifeh, Ghassan K. Abou‐Alfa, Ali Shamseddine. Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. Asia-Pacific Journal of Clinical Oncology 2022; 18(6): 735 doi: 10.1111/ajco.13775
|
| 31 |
Karoly Szepeshazi, Andrew V. Schally, Norman L. Block, Gabor Halmos, Mehrdad Nadji, Luca Szalontay, Irving Vidaurre, Andrew Abi-Chaker, Ferenc G. Rick. Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108. Oncotarget 2013; 4(5): 751 doi: 10.18632/oncotarget.1044
|
| 32 |
Ferda Kaleağasıoğlu, Martin R Berger. SIBLINGs and SPARC families: Their emerging roles in pancreatic cancer. World Journal of Gastroenterology 2014; 20(40): 14747-14759 doi: 10.3748/wjg.v20.i40.14747
|
| 33 |
M Nakamura, H Sugimoto, T Ogata, K Hiraoka, H Yoda, M Sang, M Sang, Y Zhu, M Yu, O Shimozato, T Ozaki. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Oncogenesis 2016; 5(6): e233 doi: 10.1038/oncsis.2016.40
|
| 34 |
Carlos Fortea-Sanchis, Luis Gómez-Quiles, David Martínez-Ramos, Javier Escrig Sos, Gabriel Alejandro Paiva-Coronel, Raquel Queralt-Martín, Álvaro Villarín-Rodríguez, Laura Granel-Villach, José Luis Salvador-Sanchis. Rentabilidad diagnóstica de la punción percutánea pancreática en función del tamaño de la lesión. Cirugía Española 2013; 91(6): 361 doi: 10.1016/j.ciresp.2012.10.019
|
| 35 |
Hassan Aziz, Muhammad Zeeshan, Tun Jie, Felipe B. Maegawa. Neoadjuvant Chemoradiation Therapy is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer. The American Surgeon™ 2019; 85(11): 1276 doi: 10.1177/000313481908501136
|
| 36 |
Samantha J. Wade, Zeliha Sahin, Ann‐Katrin Piper, Sepehr Talebian, Morteza Aghmesheh, Javad Foroughi, Gordon G. Wallace, Simon E. Moulton, Kara L. Vine. Dual Delivery of Gemcitabine and Paclitaxel by Wet‐Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation. Advanced Healthcare Materials 2020; 9(21) doi: 10.1002/adhm.202001115
|
| 37 |
Emelie Karnevi, Liv Ben Dror, Adil Mardinoglu, Jacob Elebro, Margareta Heby, Sven-Erik Olofsson, Björn Nodin, Jakob Eberhard, William Gallagher, Mathias Uhlén, Karin Jirström. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification. Oncotarget 2018; 9(5): 6188 doi: 10.18632/oncotarget.23486
|
| 38 |
Claudia Fiorini, Marco Cordani, Giovanni Gotte, Delia Picone, Massimo Donadelli. Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2015; 1853(3): 549 doi: 10.1016/j.bbamcr.2014.12.016
|
| 39 |
Lei Huang, Lina Jansen, Yesilda Balavarca, Lydia van der Geest, Valery Lemmens, Liesbet Van Eycken, Harlinde De Schutter, Tom B. Johannesen, Maja Primic‐Žakelj, Vesna Zadnik, Margit Mägi, Dianne Pulte, Petra Schrotz‐King, Hermann Brenner. Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003–2014: a large international population‐based study. International Journal of Cancer 2018; 143(12): 3227 doi: 10.1002/ijc.31628
|
| 40 |
Angela Zaccagnino, Antonella Managò, Luigi Leanza, Artur Gontarewitz, Bernhard Linder, Michele Azzolini, Lucia Biasutto, Mario Zoratti, Roberta Peruzzo, Karen Legler, Anna Trauzold, Holger Kalthoff, Ildiko Szabo. Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(24): 38276 doi: 10.18632/oncotarget.11299
|
| 41 |
Christos Svoronos, Georgios Tsoulfas, Anastasios Katsourakis, Georgios Noussios, Euthymmios Chatzitheoklitos, N. Georgios Marakis. Role of extended lymphadenectomy in the treatment of pancreatic head adenocarcinoma: review and meta‐analysis. ANZ Journal of Surgery 2014; 84(10): 706 doi: 10.1111/ans.12423
|